These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8749009)

  • 1. Immunochemical methods for quantification of human apolipoprotein C-III.
    Kashyap ML
    Methods Enzymol; 1996; 263():208-18. PubMed ID: 8749009
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of apolipoprotein C-II by immunochemical and chromatographic methods.
    Connelly PW; Vezina C; Maguire GF
    Methods Enzymol; 1996; 263():188-208. PubMed ID: 8749008
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme linked immunosorbent assay for human apolipoprotein C-III.
    Bury J; Rosseneu M
    J Clin Chem Clin Biochem; 1985 Feb; 23(2):63-8. PubMed ID: 3989478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of anti-apolipoprotein CIII antibodies by exploiting their affinity for apolipoprotein CIII linked to polyacrylamide gel after isoelectric focusing.
    Alsayed N; Drüeke TB; Lacour B
    Clin Chem; 1988 Jan; 34(1):49-52. PubMed ID: 3338184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of apolipoprotein C-III in normal and in hyperlipaemic serum samples by enzyme-linked immunosorbent assay.
    Riesen WF; Sturzenegger E
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():66-72. PubMed ID: 3827187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzymometric assay.
    Parsy D; Clavey V; Fievet C; Kora I; Duriez P; Fruchart JC
    Clin Chem; 1985 Oct; 31(10):1632-5. PubMed ID: 3899407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein CII & CIII in non-insulin dependent diabetic patients.
    Kodikara M; Hobbs CG; Bordin P; Pacy PJ; Venkatasan S; Halliday D
    Biochem Soc Trans; 1996 May; 24(2):172S. PubMed ID: 8736830
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of triglyceride-rich lipoproteins in progression of atherosclerosis.
    Havel RJ
    Circulation; 1990 Feb; 81(2):694-6. PubMed ID: 2297871
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein C-II deficiency.
    Breckenridge WC
    Adv Exp Med Biol; 1986; 201():211-26. PubMed ID: 3541516
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia.
    Kashyap ML; Hynd BA; Robinson K; Gartside PS
    Metabolism; 1981 Feb; 30(2):111-8. PubMed ID: 7464559
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: apo B with apo C-III and apo B with apo E.
    Kandoussi A; Cachera C; Parsy D; Bard JM; Fruchart JC
    J Immunoassay; 1991; 12(3):305-23. PubMed ID: 1939663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human apolipoprotein C-II quantitation by sandwich enzyme-linked immunosorbent assay.
    Bury J; Michiels G; Rosseneu M
    J Clin Chem Clin Biochem; 1986 Jul; 24(7):457-63. PubMed ID: 3734708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma apolipoproteins: their role in cardiovascular diseases and usefulness of their blood concentration determination. Committee of the Study of Apolipoproteins, Italian Heart Foundation].
    Cardiologia; 1997 Feb; 42 Suppl 1():1-39. PubMed ID: 9147845
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies of predetermined specificity to apolipoprotein C-II elicited with a synthetic peptide. Characterization and use for immunoassays.
    Delpierre C; Fievet C; Equagoo V; Mezdour H; Cachera C; Gesquière JC; Tartar A; Fruchart JC
    J Immunol Methods; 1988 Apr; 109(1):61-8. PubMed ID: 2451696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays.
    Bren ND; Rastogi A; Kottke BA
    Mayo Clin Proc; 1993 Jul; 68(7):657-64. PubMed ID: 8350639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout.
    Macfarlane DG; Midwinter CA; Dieppe PA; Bolton CH; Hartog M
    Ann Rheum Dis; 1985 Jun; 44(6):390-4. PubMed ID: 4015201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins in obese girls.
    Blackett PR; Germany R; Sambo B; Alaupovic P
    Clin Chem; 2003 Feb; 49(2):303-6. PubMed ID: 12560355
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and properties of human apolipoproteins C-I, C-II, and C-III.
    Jackson RL; Holdsworth G
    Methods Enzymol; 1986; 128():288-97. PubMed ID: 3724507
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia.
    Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
    Miner Electrolyte Metab; 1999; 25(4-6):258-62. PubMed ID: 10681649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of the distribution of apolipoprotein C-III in serum lipoproteins].
    Ikeda H
    Rinsho Byori; 2003 Jul; 51(7):609-14. PubMed ID: 12924243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.